The Therapeutic Effect of Inhaled Iloprost in Newborn Infants with Severe Persistent Pulmonary Hypertension Refractory to Inhaled Nitric Oxide / 대한주산의학회잡지
Korean Journal of Perinatology
;
: 57-63, 2011.
Artículo
en Coreano
| WPRIM
| ID: wpr-213539
ABSTRACT
Inhaled iloprost, a stable carbacyline derivative of prostacyclin, has been used recently for the treatment of adults with pulmonary hypertension but only few reports are available about its use in neonatal critical care. We report therapeutic trial of inhaled iloprost in newborn infants with persistent pulmonary hypertension of the newborn (PPHN) who did not respond to inhaled nitric oxide (iNO). Inhaled iloprost (Ventavis(R), Bayer Shering Pharma, Germany) was effective in neonates with severe PPHN who showed inadequate response to iNO. We suggest that inhaled iloprost could be considered as an additional therapeutic option in PPHN refractory to iNO.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Iloprost
/
Epoprostenol
/
Cuidados Críticos
/
Hipertensión Pulmonar
/
Óxido Nítrico
Límite:
Adulto
/
Humanos
/
Recién Nacido
Idioma:
Coreano
Revista:
Korean Journal of Perinatology
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS